Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

  • There is currently no data for BRH

Trading Statement

1 Oct 2008 07:00

RNS Number : 7739E
Braveheart Investment Group plc
01 October 2008
 



1 October 2008 

Braveheart Investment Group plc

("Braveheart" or the "Group")

TRADING UPDATE

Braveheart (AIM: BRH), the technology commercialisation and investment management company, today provides an update on trading for the first half of its financial year to 30 September 2008.

The Group has maintained its investment programme throughout the first half despite increasingly difficult market conditions. The main focus has been on supporting the existing portfolio by way of both equity and debt. In the current market conditions, in which investors are increasingly risk averse, the Group is reducing its risk profile by providing a higher proportion of fixed income instruments with associated equity rights than has hitherto been the case.

During the period a first closing of the Strathclyde Innovation Fund ("SIF") has been achieved with initial commitments totaling £4.5 million from investors comprising Braveheart, the University of Strathclyde and Strathclyde alumni. This also includes Scottish Enterprise's Scottish Co-investment Fund, which has agreed to co-invest alongside SIF by committing an allocation specifically for use by SIF. The commitments made at the first close are over a five year period and provision has been made for additional closings to bring in other potential partners over the next two years. As has been previously noted, the SIF will have the exclusive right of first refusal to fund all commercial investment opportunities that arise in respect of intellectual property emanating from the university.

However, the second proposed fund, being that with the University of Edinburgh, will not now be marketed. Braveheart advised the University of Edinbugh that it was not confident of achieving a satisfactory closing of this fund in the current market conditions and the University decided to undertake a review of its IP commercialisation strategy rather than waiting for markets to improve. In the meantime, Braveheart will continue to fund selected spin-outs from the University of Edinburgh by way of its Alpha EIS Fund.

The Group is maintaining its strategy to expand its presence across the UK from its Scottish base. The Group is currently recruiting and expects to make a number of appointments shortly. These new appointments will reflect Braveheart's desire to build a stronger client base in England and will lead to the opening of a London office. This initiative will ensure that Braveheart is well positioned when the markets recover and the appetite for early stage technology investing strengthens.

The Group has witnessed a challenging first half with difficult trading conditions in the capital markets. This has led to reduced levels of activity and will result in a reduction in turnover at the interim stage. In the absence of any realisations due to the prevailing market conditions, the effect of this reduced activity will be a net loss for the period. Notwithstanding, the Group ended the period with a strong balance sheet with some £4 million of cash and as such is, in the opinion of the directors, well positioned to take advantage of opportunities created from the downturn in markets and the economy more generally.

 

The Group expects to announce interim results for the half year to 30 September 2008 in early December.

Commenting, Geoffrey Thomson, Chief Executive of Braveheart said, "This has been a difficult summer for everyone in the financial services industry and Braveheart is no exception. We have witnessed widespread disruption in the capital markets and consequent retrenchment and caution on the part of investors. However, we are working through the current turmoil and continuing with our stated strategy. This will ensure that we are well placed for accelerated growth as markets improve."

He added: "We have strong cash reserves and will be progressing our expansion as planned in what has become a buyers' market. We continue to make select investments and support our portfolio and we are pleased to have achieved a first close of the Strathclyde Innovation Fund in the most difficult market conditions that most us can remember. I look forward to updating investors with further news of our progress at the time of our interim results."

For further information please visit www.braveheart-ventures.co.uk or contact:

Braveheart Investment Group

Tavistock Communications (for Braveheart)

Geoffrey Thomson, Chief Executive

Simon Hudson / Clemmie Carr 

Tel: 01738 587555

Tel: 020 7920 3150

gthomson@braveheart-ventures.co.uk

ccarr@tavistock.co.uk 

Notes to Editors

Braveheart Investment Group is a technology commercialisation and investment management company based in PerthScotland. Since its formation in 1997 it has made the transition from start-up angel syndicate to fully listed company. Braveheart's shares listed on AIM in March 2007.

Investments are made in young, emerging, unlisted companies where there is potential for significant growth through successful commercialisation of IP and Braveheart enjoys close relationships with several universities to identify emerging technologies. Investments are predominantly technology-focused, however the Group also maintains limited exposure to more traditional businesses.

Braveheart's diverse portfolio currently comprises over 30 companies and it has completed over 70 deals in its ten year history, including 6 IPOs, 3 trade sales and 8 write-offs and has an exit IRR of 33%.

At the 2008 Ernst & Young Entrepreneur of The Year Awards (Scotland) Braveheart CEO Geoffrey Thomson was given a special award recognising his contribution and support of emerging technology businesses in Scotland over the past decade. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGGFLRGKGRZM
Date   Source Headline
10th Oct 20251:20 pmRNSConfirmation of change of name and website
26th Sep 20257:00 amRNSProposed Change of Name
9th Sep 20257:00 amRNSBlock admission six monthly return
2nd Sep 202511:23 amRNSHolding(s) in Company
1st Aug 20253:04 pmRNSResult of AGM
9th Jul 20252:41 pmRNSFinal Results and Notice of AGM
30th May 20255:00 pmRNSTotal Voting Rights
27th May 20253:15 pmRNSHolding(s) in Company
21st May 20257:00 amRNSResult of Broker Option and Total Voting Rights
16th May 20252:08 pmRNSPlacing to raise £135,000
14th May 202511:55 amRNSHolding(s) in Company
18th Mar 202510:30 amRNSSubscription in IQ-AI Ltd Placing
6th Mar 202510:03 amRNSBlock admission six monthly return
3rd Feb 20257:00 amRNSCancellation of options
20th Jan 20255:32 pmRNSDirector/PDMR Shareholding - acquisition of shares
14th Jan 202511:15 amRNSHolding(s) in Company
8th Jan 20254:54 pmRNSChange of Auditor
10th Dec 20241:28 pmRNSDirector/PDMR Shareholding
9th Dec 202412:16 pmRNSDirector/PDMR Shareholding - acquisition of shares
2nd Dec 20244:22 pmRNSHolding(s) in Company
2nd Dec 20249:05 amRNSDirector/PDMR Shareholding
7th Nov 202411:10 amRNSHolding(s) in Company
7th Nov 202411:06 amRNSDirector/PDMR Shareholding - acquisition of shares
15th Oct 202410:28 amRNSHolding(s) in Company
15th Oct 20247:00 amRNSHalf-year Report
11th Oct 202410:00 amRNSInvestment in IQ-AI Limited and RPT
26th Sep 20249:35 amRNSAppointment of representative to Board of Autins
9th Sep 202410:15 amRNSBlock admission six monthly return
4th Sep 20247:00 amRNSHolding(s) in Company
20th Aug 20245:15 pmRNSHolding(s) in Company
7th Aug 20247:00 amRNSHolding(s) in Company
7th Aug 20247:00 amRNSAcquisition of interest in Image Scan Holdings plc
6th Aug 20245:30 pmRNSHolding(s) in Company
1st Aug 20247:00 amRNSInvestment update – Gyrometric
24th Jul 20247:00 amRNSInvestment update - Kirkstall and Paraytec
24th Jul 20247:00 amRNSHolding(s) in Company
18th Jul 20242:23 pmRNSResult of AGM
15th Jul 20244:27 pmRNSGrant of options
26th Jun 20242:03 pmRNSAcquisition of further interest in Autins Group
21st Jun 20247:00 amRNSFinal Results and Notice of AGM
15th May 202411:22 amRNSRevaluation of portfolio assets
29th Apr 20242:07 pmRNSHolding(s) in Company
29th Apr 20241:42 pmRNSBlock admission six monthly return
10th Apr 20247:00 amRNSHolding(s) in Company
27th Mar 202412:03 pmRNSHolding(s) in Company
6th Mar 20247:00 amRNSAcquisition of further interest in Autins Group
4th Mar 202411:48 amRNSInvestment update – Paraytec Limited
4th Mar 20247:00 amRNSCompletion of sale of Phasefocus
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.